J&J expects jump in COVID vaccine sales in 2022, eyes device deals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to J&J expects jump in COVID vaccine sales in 2022, eyes device deals
Johnson & Johnson (NYSE: JNJ) Delayed: 270.22 --0 (-0%)
Previous Close $270.22    52 Week High $126.07 
Open $270.22    52 Week Low $94.28 
Day High $270.22    P/E 56.18 
Day Low $270.22    EPS $4.81 
Volume 2,684